Alteration of growth-related proto-oncogene expression in diabetic glomeruli by a specific endothelin receptor A antagonist

Nephrology Dialysis Transplantation

Volumn 11, Issue 8, 1996, Pages 1528-1531

  Nakamura, T ^a   Ebihara, I ^a   Tomino, Y ^a   Koide, H ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell proliferation; Diabetes; Endothelin; Endothelin receptor antagonist; Proto oncogene

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; CYCLINE; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; GLUCOSE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; GENE EXPRESSION; GLOMERULUS; GLUCOSE BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C FOS; ONCOGENE C JUN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTO ONCOGENE; RAT; STREPTOZOCIN DIABETES;

EID: 0029899482     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.8.1528     Document Type: Article

References (18)

1. Yang CW, Hattori M, Vlassara H et al. Overexpression of transforming growth factor-β1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J Am Soc Nephrol 1995; 5: 1610-1617
2. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 1992; 41: 1520-1527
3. Nakamura T, Fukui M, Ebihara I et al. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993; 42: 450-456
4. Shankland SJ, Scholey JW, Ly H, Thai K. Expression of growth-related proto-oncogenes during diabetic renal hypertrophy. Kidney Int 1995; 47: 782-788
5. Wolf G, Sharma K, Ericksen M, Ziyadeh FN. High glucose-induced proliferation in mesangial cells in reversed by autocrine TGF-β1. Kidney Int 1992; 42: 647-656
6. Kreisberg JI, Radnik RA, Ayo SH, Garoni J, Saikumar P. High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures. Kidney Int 1994; 46: 105-112
7. Haynes WG, Webb DJ. The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci 1993; 84: 485-500
8. Benigni A, Zoja C, Corna D et al. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993; 44: 440-444
9. Nakamura T, Ebihara I, Tomino Y, Koide H. Effect of a specific endothelin A receptor antagonist on murine lupus nephritis. Kidney Int 1995; 47: 481-489
10. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
11. Matsumoto K, Moriuchi T, Koji T, Nakane PK. Molecular cloning of cDNA coding for rat proliferating cell nuclear antigen (PCNA/cyclin). EMBO J 1987; 6: 637-642
12. Zoja C, Orisio S, Perico N et al. Constitutive expression of endothelin gene in cultured human mesangial cells and its modulation by transforming growth factor-β, thrombin, and a thromboxane A2 analogue. Lab Invest 1991; 64: 16-25
13. Fukui M, Nakamura T, Ebihara I et al. Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med 1993; 122: 149-156
14. Zatz R, Meyer TW, Renke HG, Brenner BM. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985; 82: 5963-5967
15. Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988; 238: 249-252
16. Simonson MS, Jones JM, Dunn MJ. Differential regulation of fos and jun gene expression and AP-1 cis-element activity by endothelin isopeptides. J Biol Chem 1992; 267: 8643-8649
17. Simonson MS, Herman WH. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. J Biol Chem 1993; 268: 9347-9357
18. Cameron NE, Dines KC, Cotter MA. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats. Diabetologia 1994; 37: 1209-1215